Showing results (281-290 of 1,984) with videos related to
Sort By:
Pageof 199
International Journal of Immunopharmacology|January 4, 2001
Thymosin alpha 1 in the treatment of cancer: from basic research to clinical applicationE Garaci, F Pica, G Rasi, et al.International Journal of Immunopharmacology|January 4, 2001
Immunostimulation by bacterial components: II. Efficacy studies and meta-analysis of the bacterial extract OM-89M Huber, K Krauter, G Winkelmann, et al.International Journal of Immunopharmacology|January 1, 1988
Increase in the number and the phagocytic function of guinea pig pulmonary and peritoneal macrophages following oral administration of RU 41740, a glycoprotein extract from Klebsiella pneumoniaeM Radermecker, M Rommain, M P Maldague, et al.International Journal of Immunopharmacology|January 1, 1988
Macrolidic antibiotics: effects on primary in vitro antibody responsesM L Villa, F Valenti, M Mantovani, et al.International Journal of Immunopharmacology|January 1, 1988
Non-toxic endotoxin polysaccharide induces soluble mediators which potentiate antibody production by murine retrovirus-suppressed splenocytesH Friedman, R C Butler, S Specter, et al.International Journal of Immunopharmacology|January 1, 1979
Presence of thymosin-like factors in human thymic epithelium conditioned mediumL Kater, R Oosterom, J McClure, et al.International Journal of Immunopharmacology|January 1, 1987
Suppression of T-helper cell function in mice following exposure to the carcinogen 7,12-dimethylbenz[a]anthracene and its restoration by interleukin-2R V House, L D Lauer, M J Murray, et al.International Journal of Immunopharmacology|January 1, 1988
Altered lymphocyte proliferation of immunized rats after neurological manipulation with capsaicinG Nilsson, S AhlstedtInternational Journal of Immunopharmacology|January 1, 1988
Immunotherapy of patients with terminal-stage malignant tumors with an immunopotentiator OK-432--a comparison of SU-PS test-responding and -nonresponding patientsY Yagi, S YagiInternational Journal of Immunopharmacology|April 1, 1992
Synergy in the toxicity of cytokines: preclinical studiesJ E TalmadgePageof 199